ABSTRACT
Fungi can cause severe infections. Two or more nosocomial unusual fungal infections diagnosed in a short period should be assumed as an outbreak. The review's aim was to collect data to improve their management. The free online worldwide database for nosocomial outbreaks ( http://www.outbreak-database.com ) and the PubMed/MEDLINE database were used to collect the English literature published from 1990 to June 2011. The more common Candida spp. and Aspergillus spp. infections were excluded. For each outbreak, the following data were reviewed: species, duration, source and site of infection, ward, risk factors, number of patients infected, treatment, related mortality, type of epidemiological study and time elapsed between index cases and second cases. Thirty-six reports were considered: yeasts caused the majority of the outbreaks (16 out of 36). The median values for the overall duration, number of infected people per outbreak and infection-related mortality were 5 months, 4 and 20 %, respectively. Eighteen cases were caused by contaminated substances and 13 cases were hypothesised as human-transmitted. Nosocomial outbreaks due to rare fungal pathogens involve few patients but have high related mortality. These results could be explained by the diagnostic delay, the inability of recognising the source of the infections and the challenges of the treatment. More efforts should be concentrated to implement the application of proper hygiene practices to avoid human-human transmission.
Subject(s)
Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Mycoses/epidemiology , Mycoses/microbiology , Antifungal Agents/administration & dosage , Cross Infection/drug therapy , Cross Infection/mortality , Fungi/classification , Fungi/isolation & purification , Humans , Mycoses/drug therapy , Mycoses/mortality , Risk Factors , Survival Analysis , Time Factors , Treatment OutcomeABSTRACT
The risk of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab for multiple sclerosis (MS) is a serious concern. The presence of anti-JC virus antibodies is a risk factor for PML development, but 2.5 % of the patients result falsely-negative, while the prognostic relevance of testing JCV-DNA in biological fluids of treated patients is debated. Aim of this work was to evaluate the utility of testing JCV-DNA, together with anti-JCV antibodies, in biological samples of treated patients as a tool for PML risk stratification. 126 subjects from 5 MS Centers in Italy were included in the study. We performed a cross-sectional study in 63 patients testing JCV-DNA in blood, peripheral blood cells and urine. We longitudinally assessed the presence of JCV-DNA in a cohort of 33 subjects, one of which developed PML. We could test retrospectively serum samples from another PML case occurred during natalizumab therapy. Anti-JCV antibodies and urinary JCV-DNA were both tested in 73 patients. No changes in JCV-DNA status occurred during natalizumab treatment. The subject who developed PML in the longitudinal cohort had detectable JCV-DNA in urine at all time-points while serum or blood from both PML patients were always negative before the onset of disease and, in one case, after. Four subjects with JCV-DNA in urine and undetectable anti-JCV antibodies were retested for anti-JCV antibodies and three out of four resulted positive. In conclusion, testing JCV-DNA in urine is complementary to testing anti-JCV antibodies in identifying patients at risk of PML.
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , DNA, Viral/urine , JC Virus/metabolism , Leukoencephalopathy, Progressive Multifocal/diagnosis , Leukoencephalopathy, Progressive Multifocal/urine , Adult , Biomarkers/urine , Cross-Sectional Studies , Diagnostic Tests, Routine , Female , Humans , Leukoencephalopathy, Progressive Multifocal/drug therapy , Longitudinal Studies , Male , Middle Aged , Natalizumab , Retrospective Studies , Risk Factors , Young AdultABSTRACT
We describe the greatest Italian human acute opisthorchiasis outbreak acquired from eating raw tenches. Out of 52 people with suspected opisthorchiasis, 45 resulted in being infected. The most frequent symptoms and laboratory findings were fever, abdominal pain and eosinophilia. Seven tri-phasic computed tomography (CT) scans were done, showing multiple hypodense nodules with hyper-enhancement in the arterial phase. All patients took one day of praziquantel 25 mg/kg TID without failures. Reported symptoms suggested a febrile eosinophilic syndrome with cholestasis rather than a hepatitis-like syndrome. It seems common to find hepatic imaging alterations during acute opisthorchiasis: CT scan could be the most suitable imaging examination. Even if stool test remains the diagnostic gold standard, we found earlier positivity with the serum antibody test. Without previous freezing, the consumption of raw freshwater fish should be avoided.
Subject(s)
Cholestasis/pathology , Disease Outbreaks , Eosinophilia/pathology , Fever/physiopathology , Opisthorchiasis/epidemiology , Opisthorchiasis/pathology , Opisthorchis/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Anthelmintics/administration & dosage , Child , Female , Foodborne Diseases/epidemiology , Foodborne Diseases/pathology , Hepatitis/pathology , Humans , Italy/epidemiology , Male , Middle Aged , Praziquantel/administration & dosage , Radiography, Abdominal , Tomography, X-Ray Computed , Young AdultABSTRACT
A collaborative project was established between the Alli Causai Foundation in Ambato, Ecuador, and the University of Genoa, Italy, to introduce the microscopic observation drug susceptibility (MODS) assay for the rapid identification of Mycobacterium tuberculosis in Ecuador. A total of 507 samples were evaluated during a 10-month period, and DNA was extracted from each isolate and sent to Genoa for confirmatory molecular analysis. M. tuberculosis was identified in 45 samples by MODS, and drug resistance was observed in approximately 21% of the isolates, with four multidrug-resistant strains detected in two patients.
Subject(s)
Antitubercular Agents/therapeutic use , DNA, Bacterial/genetics , Drug Resistance, Multiple, Bacterial/genetics , Mutation , Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Multidrug-Resistant/diagnosis , Colony Count, Microbial/methods , Ecuador/epidemiology , Humans , Incidence , Mycobacterium tuberculosis/genetics , Polymerase Chain Reaction , Prevalence , Retrospective Studies , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/epidemiologyABSTRACT
No disponible
Subject(s)
Humans , Renal Dialysis/methods , Renal Insufficiency, Chronic/therapy , Exercise Therapy/adverse effects , Risk FactorsABSTRACT
Cunninghamella bertholletiae infection occurs most frequently in neutropenic patients affected by haematological malignancies, is associated with an unfavourable outcome. We report a case of rhino-mastoidal fungal infection in a leukaemic patient. Bioptical tissue cultures yield the isolation of a mould with typical properties of Cunninghamella species. Liposomal amphotericin B (L-Amb) therapy combined with surgical intervention brought the lesion to recovery. Nevertheless, the patient died 14 days after bone marrow transplantation (BMT) from bacterial sepsis. Mastoiditis was documented at CT-scan. The conditioning regimen probably caused the reactivation of the Cunninghamella infection that led to the patient's fatal outcome; fungal hyphae were detected after autopsy of brain and lung tissue.
Subject(s)
Amphotericin B/pharmacokinetics , Bone Marrow Transplantation/adverse effects , Cunninghamella/drug effects , Leukemia, Myeloid/complications , Mucormycosis/etiology , Amphotericin B/therapeutic use , Cunninghamella/pathogenicity , Humans , Immunocompromised Host , Leukemia, Myeloid/drug therapy , Leukemia, Myeloid/metabolism , Leukemia, Myeloid/microbiology , Leukemia, Myeloid/surgery , Mucormycosis/metabolism , Opportunistic Infections/etiology , Opportunistic Infections/metabolismABSTRACT
We describe a case of primary cutaneous Absidia corymbifera infection in an AIDS patient with renal complications. The Sensititre YeastOne panel was adopted to determine antifungal susceptibility and liposomial amphotericin B was used which initially produced a significant clinical response.